HL-085 in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
Clinical trial NCT05331105 · RECRUITING
Trial details
- NCT number
- NCT05331105
- Sponsor
- Shanghai Kechow Pharma, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-18
- Primary completion
- 2025-10-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.